Received Dec 26, 2025
| Type | Name | Manufacturer | Dose | Lot | Route / Site |
|---|---|---|---|---|---|
| HEPA | HEP A (HAVRIX) | GLAXOSMITHKLINE BIOLOGICALS | 2 | HR4RB | — |
AE - Havrix - Expired dose administered; Drug dose administration interval too long; This non-serious case was reported by a pharmacist via call center representative and described the occurrence of expired vaccine used in a 74-year-old female patient who received HAV (Havrix) (batch number HR4RB, expiry date 18-DEC-2025) for prophylaxis. Previously administered products included Havrix (first dose was given in 2009). On 19-DEC-2025, the patient received the 2nd dose of Havrix. On 19-DEC-2025, an unknown time after receiving Havrix, the patient experienced expired vaccine used (Verbatim: AE - Havrix - Expired dose administered) and drug dose administration interval too long (Verbatim: Drug dose administration interval too long). The outcome of the expired vaccine used and drug dose administration interval too long were not applicable. This report is made by GSK without prejudice and does not imply any admission or liability for the incident or its consequences. Additional Information: GSK receipt date: 19-DEC-2025 The reporter asked if it was a valid dose or it has a grace period.